Lipid microdomain-mediated signaling: Implications for anti-MOG mediated demyelinating disease

被引：0
|
作者：
Pfeiffer, S. E.
Marta, C. B.
Olive, A. R.
Sweet, R. A.
Bansal, R.
Ruddle, N. H.
机构：
[1] Univ Connecticut, Sch Med, Farmington, CT USA
[2] Yale Univ, Sch Med, New Haven, CT USA
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2006年 / 178卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [21] MOG antibody-associated demyelinating disease mimicking typical multiple sclerosis: A case for expanding anti-MOG testing?
    Breza, Marianthi
    Koutsis, Georgios
    Tzartos, John S.
    Velonakis, Georgios
    Evangelopoulos, Maria Eleftheria
    Tzanetakos, Dimitrios
    Karagiorgou, Katerina
    Angelopoulou, Georgia
    Kasselimis, Dimitrios
    Potagas, Constantin
    Anagnostouli, Maria
    Stefanis, Leonidas
    Kilidireas, Constantinos
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 : 67 - 69
  • [22] Anti-MOG antibody-positive meningoencephalitis without demyelinating lesions
    Yamane, Tetsuya
    Ueda, Takuya
    Nishiyama, Masahiro
    Hongo, Hiroto
    Ishida, Yusuke
    Maruyama, Azusa
    PEDIATRICS INTERNATIONAL, 2023, 65 (01)
  • [23] In silico analysis of microdomain-mediated trimer formation in the T cell membrane
    E. Long
    B. Henderson
    A. Zaikin
    The European Physical Journal Special Topics, 2010, 187 : 21 - 30
  • [24] In silico analysis of microdomain-mediated trimer formation in the T cell membrane
    Long, E.
    Henderson, B.
    Zaikin, A.
    EUROPEAN PHYSICAL JOURNAL-SPECIAL TOPICS, 2010, 187 (01): : 21 - 30
  • [25] THE NEWCASTLE EXPERIENCE OF ANTI-MOG ASSOCIATED DISEASE
    Bolton, Clare
    Chapman, James
    Ledingham, David
    Lewis-Smith, David
    Spyropoulos, Achillefs
    Guadagno, Joe
    Duddy, Martin
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (12):
  • [26] Rab3 regulates microdomain-mediated plasma membrane recycling
    Levental, K. R.
    Diaz-Rohrer, B.
    Castello-Serrano, I.
    Wang, H. -Y.
    Levental, I.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 249 - 249
  • [27] Steroid responsive anti-MOG antibody mediated meningo-encephalomyelitis and optic neuritis
    Truong, Melanie
    Hitt, Brian
    Dubey, Divyanshu
    Ortstadt, Jeff
    NEUROLOGY, 2017, 88
  • [28] Anti-MOG antibodies induce complement mediated demyelination in isolated optic neuritis and myelitis
    Tortorella, C.
    Direnzo, V.
    Palazzo, C.
    Cibelli, A.
    Luciannatelli, E.
    Mastrapasqua, M.
    Paolicelli, D.
    Iaffaldano, P.
    Ruggieri, M.
    Nicchia, P.
    Frigeri, A.
    Trojano, M.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 98 - 99
  • [29] Relevance of serum anti-MOG antibodies for diagnosis and characterization of CNS demyelinating disorders
    Mariotto, S.
    Ferrari, S.
    Monaco, S.
    Benedetti, M. D.
    Turatti, M.
    Calabrese, M.
    Alberti, D.
    Farinazzo, A.
    Capra, R.
    De Rossi, N.
    Deotto, L.
    Bonora, A.
    Pavone, A.
    Cadaldini, M.
    Polo, A.
    Bianchi, M. R.
    Bombardi, R.
    Cantalupo, G.
    Shanda, K.
    Reindl, M.
    Gajofatto, A.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 88 - 89
  • [30] Exploring the epitopes of anti-MOG antibodies in the patients with inflammatory demyelinating disease presenting various clinical phenotypes
    Koike, N.
    Kawamura, M.
    Ohno, M.
    Sakimura, K.
    Tanaka, K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 648 - 649
12345